Bio-Rad Laboratories, Inc. (BIO) vs 23andMe Holding Co. (ME)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and 23andMe Holding Co. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 30, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$327.25HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
ME
23andMe Holding Co.
$0.61HealthcareAt close: Mar 19, 2026, 4:00 PM ET
Total return — BIO vs ME
growth of $100 · dividends reinvested · last 5yBIO -53.7%ME -99.7%BIO compounded faster
Log scale — wide-divergence pair
BIO ME
BIO vs ME: by the numbers
- •BIO is the larger company ($8.85B vs $15M market cap).
- •BIO is profitable (6.52% net margin) while ME runs a net loss (-134.54%).
- •BIO grew revenue faster over the past five years (0.29% vs -9.07% CAGR).
Metrics side by side
Valuation
| Metric | BIO | ME |
|---|---|---|
| P/E ratio | 53.91 | N/A |
| Forward P/E | 36.19 | N/A |
| P/S ratio | 3.41 | 0.10 |
| P/B ratio | 1.29 | 0.51 |
| EV / EBITDA | 22.15 | N/A |
| FCF yield | 4.05% | N/A |
Profitability
| Metric | BIO | ME |
|---|---|---|
| Gross margin | 51.87% | 53.33% |
| Operating margin | 9.25% | -126.72% |
| Net margin | 6.52% | -134.54% |
| ROE | 2.46% | -721.75% |
| ROIC | 2.04% | -553.10% |
Growth (annualized)
| Metric | BIO | ME |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | -9.07% |
| EPS CAGR (5Y) | -26.27% | N/A |
| FCF CAGR (5Y) | -7.57% | N/A |
| Total return CAGR (5Y) | -14.28% | -68.93% |
Frequently asked
- Which has grown faster, BIO or ME?
- Over the past five years, BIO grew revenue faster — BIO at a 0.29% CAGR versus ME at -9.07%.
- Is BIO or ME more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus ME at -134.54%.
- How have BIO and ME total returns compared?
- Over the past 5 years, BIO delivered 8.47% and ME delivered -68.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratio23andMe P/E ratioBio-Rad Laboratories dividend yield23andMe dividend yieldBio-Rad Laboratories ROE23andMe ROEBio-Rad Laboratories operating margin23andMe operating marginBio-Rad Laboratories revenue growth23andMe revenue growthBio-Rad Laboratories free cash flow23andMe free cash flow
Bio-Rad Laboratories & 23andMe appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 30, 2026.